Neutral impactCompany

Cell Point (India) Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 2 hrs ago·10 Oct 2026, 7:34 am
Cell Point (India)

Cell Point (India) Limited has informed the stock exchanges that it has received a Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate confirms that the company has completed the necessary formalities for the dematerialization of its fully paid-up equity shares. It acts as official confirmation that the shares are now eligible for electronic settlement.

For investors, this development is a routine administrative milestone. It signifies that the company’s shares are fully compliant with depository regulations, ensuring they can be traded seamlessly in the electronic market. This confirmation generally reduces settlement risks and is a standard requirement for maintaining a listing on stock exchanges.

Investors should note that this is a procedural update rather than a financial event. While it confirms the company's adherence to regulatory norms, it does not provide new information regarding its business performance. Market participants should continue to focus on the company's operational metrics and market trends for future investment decisions.

Affected stocks

Neutral1 stock

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

  • Concerns Cell Point (India) (CELLPOINT).
  • Category: Company.

Why it matters

A routine update for Cell Point (India). Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.

More Company news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.